References: Pace E, Di Sano C, Ferraro M, Tipa A, Olivieri D, Spatafora M, Santagata R, Bellia V, Gjomarkaj M. Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions. Eur J Cancer. 2011 Jan;47(2):296-304. (HP-3D9, FC)
Orr MT, Wu J, Fang M, Sigal LJ, Spee P, Egebjerg T, Dissen E, Fossum S, Phillips JH, Lanier LL. Development and function of CD94-deficient natural killer cells. PLoS One. 2010 Dec 3;5(12):e15184.
Schuberth HJ, Kucinskiene G, Chu RM, Faldyna M. Reactivity of cross-reacting monoclonal antibodies with canine leukocytes, platelets and erythrocytes. Vet Immunol Immunopathol. 2007 Sep 15;119(1-2):47-55. (HP-3D9, canine, FC)
Miller JS, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood. 2001 Aug 1;98(3):705-13. (HP-3D9, FC)
Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol. 1996 Dec 1;157(11):4741-5. (HP-3D9, FC)